课题基金 / 基金详情

COVID-19: Development of Sustainable and Compostable Face Masks for Enhanced Protection Against COVID-19 Virus Particles

COVID-19: Development of Sustainable and Compostable Face Masks for Enhanced Protection Against COVID-19 Virus Particles
COVID-19:开发可持续且可堆肥的口罩,以增强对 COVID-19 病毒颗粒的防护
批准号:
554156-2020
负责人:
Tam, Michael
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Tam, Michael的其他基金

相似基金

相关文献

中文摘要
翻译
几乎所有的N95和医用口罩都是用合成纤维生产的,比如丙纶(PP)纤维。生产和使用PP作为一次性口罩将加剧与聚烯烃和聚苯乙烯等一次性塑料相关的许多问题。一种由人造天然纤维制成的新型口罩提供了一个可持续的长期解决方案,消除了上世纪80年代社会放弃使用纸袋而使用无处不在的塑料袋的陷阱。事后看来,这现在被认为是世界正在努力扭转的一个重大错误。因此,我们应该避免在合成口罩上犯同样的错误。 这项建议旨在提升森林和农业生物质,并设计它们生产防护口罩以对抗冠状病毒流行。拟议的项目将推进超疏水纸系统(SHP)或纸基口罩(PBM)的开发,这种口罩具有防水、抗菌和对负电荷病毒颗粒(VP)有很强的结合。SHP是用一种不同的造纸工艺制备的,其中由改性的纤维素纳米晶、蜡微粒和纸浆纤维组成的Pickering乳液(PE)通过吸墨纸形成SHP。SHP表现出高的水接触角(>150度--超疏水条件)和低附着力,因此水滴和含有新冠肺炎病毒颗粒的水气溶胶不能附着在其表面。我们的团队拥有生产PE的专业知识和科学知识,然后使用造纸机进行处理,形成SHP。SHP/PBM将根据ASTM F2100医用口罩标准进行评估,以确认其防止VP到达人类呼吸系统(HRS)的能力。PE配方和生产工艺可以很容易地放大,以生产大量用于商业应用的SHP/PBM。
英文摘要
Almost all the N95 and surgical masks are produced with synthetic fibers, such as polypropylene (PP) fibers. The production and use of PP as disposable face masks will aggravate many of the problems associated with single use plastics, such as polyolefins and polystyrene. A new kind of face mask manufactured from engineered natural fibers offers a sustainable long-term solution, negating the same trap as when in the 1980s, society abandoned the use of paper bags for the ubiquitous plastic bags instead. On hindsight, this is now believed to be a major mistake that the world is trying to reverse. Thus, we should avoid making the same mistake with synthetic face masks. This proposal seeks to upgrade forest and agriculture biomass and engineer them to produce protective masks to combat the Coronavirus pandemic.The proposed project will advance the development of a superhydrophobic paper system (SHP) or a paper-based mask (PBM) that is water repellant, antimicrobial, and has strong binding to negatively charged virus particles (VP). The SHP is prepared using a variant of paper making process, where the formulated Pickering emulsion (PE) consisting of modified cellulose nanocrystals, wax microparticles, and pulp fibers is passed through a blotting paper to form the SHP. The SHP displays a high water contact angle (>150 degree -a condition of superhydrophobicity) and low adhesion, such that water droplets and aqueous aerosols with COVID-19 virus particles cannot adhere to its surface. Our group has the expertise and scientific knowledge to produce the PE, which is then processed using the paper making device to form the SHP. The SHP/PBM will be evaluated according to ASTM F2100 standard for medical grade masks, confirming their capability to prevent the VPs from reaching the human respiratory system (HRS). The PE formulation and production process can be readily scaled-up to produce large volume of the SHP/PBM for commercial applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sustainable Nanomaterials for Advanced Engineering Applications
  • 批准号:
    RGPIN-2017-04236
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $10.78万
  • 财政年份:
    2021
  • 负责人:
    Tam, Michael
  • 依托单位:
Physical Properties and Colloidal Stability of Aluminium Hydroxide Adjuvants (RehydragelTM)
  • 批准号:
    570656-2021
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $2.91万
  • 财政年份:
    2021
  • 负责人:
    Tam, Michael
  • 依托单位:
Market Assessment on Functional cellulose nanocrystals for advanced engineering applications
  • 批准号:
    555705-2020
  • 项目类别:
    Idea to Innovation
  • 资助金额:
    $1.09万
  • 财政年份:
    2020
  • 负责人:
    Tam, Michael
  • 依托单位:
Dispersion of cellulose nanocrystals in aqueous media
  • 批准号:
    493270-2015
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $1.46万
  • 财政年份:
    2020
  • 负责人:
    Tam, Michael
  • 依托单位:
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位:
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位: